· Investment Strategies · 4 sources

Stoke Space’s $1B Series E: Point72 and Spark Fund Full Reuse Before First Orbit

Stoke completed an initial $1B Series E co-led by Point72 Ventures and Spark Capital — $2.3B total raised — to fly Nova Pathfinder in early 2027 and build 15-ton Nova Block 2 for 2029.

By Venture Capital Tracker Editorial

Share
Stoke Space’s $1B Series E: Point72 and Spark Fund Full Reuse Before First Orbit

Stoke Space completed an initial closing of a ~$1 billion Series E on September 8, 2026, co-led by Point72 Ventures and Spark Capital, with Y Combinator, US Innovative Technology, Glade Brook, Woven Capital, General Innovation, Washington Harbour Partners, and others participating. Cumulative capital is now $2.3 billion (company press).

Most of that cash arrives before first orbit. Pathfinder is targeted for early 2027; the raise also funds Nova Block 2 (15 metric tons to LEO, 2029 target) so Stoke is not stuck as a three-ton niche once Falcon-class demand shifts.

Key facts

Company
Stoke Space (Kent, WA; Cape Canaveral LC-14)
Round
~$1B Series E (initial close; CEO: “within rounding error” of $1B)
Co-leads
Point72 Ventures, Spark Capital (both since Series A per Payload)
Cumulative
$2.3B total raised
Valuation
~$10B — Reuters-reported, not in company press
Pathfinder
~3 t to LEO; full first+second stage reuse thesis; early 2027
Block 2
15 t to LEO, 5 m fairing; 2029 target
Prior
Series D / extension to $860M (Oct 2025–Feb 2026)

Point72 Ventures, USIT, Glade Brook, Woven, General Innovation, Washington Harbour

Who uses the product — and why they would buy

Users: constellation operators, government/defense missions, and commercial customers that need third-party launch capacity — especially if SpaceX prioritizes Starlink / Starship internal demand (thesis Lapsa and peers articulate publicly).

Job: buy flights on a fully reusable medium-lift stack (methalox first stage + actively cooled hydrolox second stage) instead of accepting expendable upper stages as the industry default.

Proof still ahead: Stoke says Pathfinder vehicles are in production and ground systems are checked out short of combined rocket+pad tests. Sold contracts are company-claimed; dollar backlog was not published in the Series E materials reviewed.

Why now

  • Launch demand signal is “more capacity, larger missions” — company language for constellation replenishment.
  • Pathfinder slipped from late 2026 talk into early 2027; capital pre-funds cadence infrastructure, not just one demo.
  • Same week, Europe’s The Exploration Company raised $450M Series C — Atlantic capital is pricing launch sovereignty and reuse in parallel (TEC deep dive).

Why Point72 + Spark — portfolio fit

DimensionFit
Point72 VenturesMulti-stage Stoke backer; hedge-fund-adjacent capital comfortable with multi-year hard-tech
Spark CapitalSame long-duration thesis: full reuse as the only cost-floor end state
YC / USITContinuity from earlier rounds; defense/innovation-flavored capital for LC-14 and factory scale
Strategic rationaleNeed factory + pad + Block 2 R&D before Pathfinder proves the architecture in flight — classic deep-tech sequencing

What remains undisclosed

  • Company-stated post-money (use Reuters ~$10B carefully)
  • Contract backlog $ value and customer names
  • Capex split Pathfinder vs Block 2 vs recovery fleet
  • Whether Series E is fully closed or still open after “initial” close

Takeaway

$1B pre-orbit is a bet that second-stage reuse is worth industrializing now, while SpaceX’s cadence creates both a competitor and a customer-spillover opportunity. The flight that matters is Pathfinder — everything else is scaffolding until that works.

Prior Stoke coverage: $350M / Series D path. Day index: September 8–9.

Follow Venture Capital Tracker on Google

Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.

Add as preferred source

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Related articles

See all

Frequently Asked Questions

Direct answers to common questions about this topic

Back to Blog